Trevilor and respiratory depression Patient Reports February 13, 2012

Trevilor Side Effects Report #5525089-8
Trevilor side effect was reported by a Physician from GERMANY on Nov 21, 2007. Female patient, weighting 154.3 lb, was treated with Trevilor. After drug was administered, patient experienced the following side effects: coma, intentional overdose, respiratory depression. Trevilor dosage: unknown. During the same period patient was treated with LAMOTRIGINE. Patient was hospitalized. Patient recovered.

Trevilor Side Effects Report #5834883-5
Trevilor side effect was reported by a Physician from GERMANY on July 31, 2008. Female patient was treated with Trevilor. After drug was administered, patient experienced the following side effects: anuria, blood creatine phosphokinase increased, blood creatinine increased, intentional overdose, respiratory depression, somnolence, suicide attempt. Trevilor dosage: 50 CAPSULES (OVERDOSE AMOUNT 7500 MG). Patient was hospitalized. Patient recovered.

Trevilor Side Effects Report #5853219-7
Trevilor side effect was reported by a Physician from GERMANY on Aug 14, 2008. Female patient, weighting 220.5 lb, was treated with Trevilor. After drug was administered, patient experienced the following side effects: anuria, blood creatine phosphokinase increased, blood creatinine increased, coma, hyperthermia, intentional overdose, mydriasis, respiratory depression, somnolence. Trevilor dosage: 40 CAPSULES (OVERDOSE AMOUNT 6000 MG). Patient was hospitalized. Patient recovered.

Trevilor Side Effects Report #5866865-1
Trevilor side effect was reported by a Physician from GERMANY on Aug 29, 2008. Male patient, weighting 286.6 lb, was treated with Trevilor. After drug was administered, patient experienced the following side effects: apathy, blood creatine phosphokinase increased, blood creatinine increased, blood sodium decreased, intentional overdose, mydriasis, renal failure, respiratory depression, suicide attempt. Trevilor dosage: MAX. 150 CAPSULES (OVERDOSE AMOUNT MAX. 11250 MG). During the same period patient was treated with ZOLPIDEM, MIRTAZAPINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, BLOPRESS. Patient was hospitalized. Patient recovered.